| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2023 |
4
| Ellingson Rachel (SVP & Chief Strategy Officer) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.|
Txns:
| Granted 4,256 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Ellingson Rachel (SVP & Chief Strategy Officer) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.|
Txns:
| Paid exercise price by delivering 361 shares
@ $124.73, valued at
$45k
Exercised 1,046 restricted stock units
@ $0 |
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/01/2016 |
4
| Ellingson Rachel (VP, Corporate Relations) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Paid exercise price by delivering 294 shares
@ $78.63, valued at
$23.1k
Exercised 875 restricted stock units
@ $0 |
|
| 12/21/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/09/2015 |
4
| Ellingson Rachel (VP, Global Communications) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Granted 2,704 restricted stock units
@ $0
Granted 25,464 options to buy
@ $61.62, valued at
$1.6M
|
|
| 09/01/2015 |
4
| Ellingson Rachel (VP, Corporate Relations) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Paid exercise price by delivering 295 shares
@ $72.62, valued at
$21.4k
Exercised 875 restricted stock units
@ $0 |
|
| 04/28/2015 |
4
| Ellingson Rachel (VP, Global Communications) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Sold 4,416 shares
@ $74, valued at
$326.8k
Exercised 1,033 options to buy
@ $48.37, valued at
$50k
Exercised 1,383 options to buy
@ $34.96, valued at
$48.3k
Exercised 2,000 options to buy
@ $35.27, valued at
$70.5k
|
|
| 03/04/2015 |
4
| Ellingson Rachel (VP, Corporate Relations) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Paid exercise price by delivering 58 shares
@ $68.36, valued at
$4k
Exercised 172 restricted stock units
@ $0 |
|
| 12/19/2014 |
4
| Ellingson Rachel (VP, Global Communications) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Paid exercise price by delivering 61 shares
@ $65.61, valued at
$4k
Paid exercise price by delivering 235 shares
@ $65.61, valued at
$15.4k
Paid exercise price by delivering 135 shares
@ $65.61, valued at
$8.9k
Exercised 179 restricted stock units
@ $0
Exercised 698 restricted stock units
@ $0
Exercised 401 restricted stock units
@ $0 |
|
| 12/10/2014 |
4
| Ellingson Rachel (VP, Global Communications) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Granted 2,228 restricted stock units
@ $0
Granted 19,616 options to buy
@ $69.08, valued at
$1.4M
|
|
| 11/03/2014 |
4
| Ellingson Rachel (VP, Corporate Relations) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Sold 1,033 shares
@ $61.84, valued at
$63.9k
Sold 4,336 shares
@ $61.84, valued at
$268.1k
Exercised 1,033 options to buy
@ $48.37, valued at
$50k
Exercised 4,336 options to buy
@ $35.27, valued at
$152.9k
|
|
| 09/03/2014 |
4
| Ellingson Rachel (VP, Corporate Relations) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Paid exercise price by delivering 294 shares
@ $65.59, valued at
$19.3k
Exercised 875 restricted stock units
@ $0 |
|
| 07/30/2014 |
4
| Ellingson Rachel (VP, Corporate Relations) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Sold 1,383 shares
@ $66.72, valued at
$92.3k
Sold 1,247 shares
@ $66.72, valued at
$83.2k
Exercised 1,383 options to buy
@ $34.96, valued at
$48.3k
Exercised 1,247 options to buy
@ $35.27, valued at
$44k
|
|
| 03/05/2014 |
4
| Ellingson Rachel (VP, Corporate Relations) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Paid exercise price by delivering 58 shares
@ $67.32, valued at
$3.9k
Exercised 172 restricted stock units
@ $0 |
|
| 12/17/2013 |
4
| Ellingson Rachel (VP, Corporate Relations) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Paid exercise price by delivering 61 shares
@ $59.42, valued at
$3.6k
Paid exercise price by delivering 235 shares
@ $59.42, valued at
$14k
Exercised 179 restricted stock units
@ $0
Exercised 698 restricted stock units
@ $0 |
|
| 12/12/2013 |
4
| Ellingson Rachel (VP, Corporate Relations) has filed a Form 4 on ST JUDE MEDICAL INC|
Txns:
| Granted 1,604 restricted stock units
@ $0
Granted 13,380 options to buy
@ $59.41, valued at
$794.9k
|
|
|